Dysregulation of the Type 1 IGF receptor as a paradigm in tumor progression

Molecular and Cellular Endocrinology

Volumn 141, Issue 1-2, 1998, Pages 1-5

  Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; Cell cycle; IGF 1 receptor; Transcription; Tumour suppressors

Indexed keywords

PROTEIN P53; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; EMBRYO; FIBROBLAST; GENETIC TRANSFORMATION; HUMAN; MOUSE; NONHUMAN; ONCOGENE; ONTOGENY; PRIORITY JOURNAL; RAT; RECEPTOR GENE; REVIEW;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; DISEASE PROGRESSION; HUMANS; NEOPLASMS; RECEPTOR, IGF TYPE 1;

EID: 0032565914     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00099-9     Document Type: Review

References (38)

1. Abbott A.M., Bueno R., Pedrini M.T., Murray J.M., Smith R.J. Insulin-like growth factor I receptor gene structure. J. Biol. Chem. 267:1992;10759-10763.
2. Baker J., Liu J.-P., Robertson E.J., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:1993;73-82.
3. Baserga R., Rubin R. Cell cycle and growth control. Crit. Rev. Euk. Gene. Exp. 3:1993;47-61.
4. Baserga R., Hongo A., Rubini M., Prisco M., Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta. 1332:1997;F105-F126.
5. Beitner-Johnson D., Werner H., Roberts C.T. Jr, LeRoith D. Regulation of insulin-like growth factor I receptor gene expression by Sp1: Physical and functional interactions of Sp1 at GC boxes and at a CT element. Mol. Endocrinol. 9:1995;1147-1156.
6. Bondy C.A., Werner H., Roberts C.T. Jr, LeRoith D. Cellular pattern of insulin-like growth factor I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol. Endocrinol. 4:1990;1386-1398.
7. Cohick W.S., Clemmons D.R. The insulin-like growth factors. Ann. Rev. Physiol. 55:1993;131-153.
8. Daughaday W., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrinol. Rev. 10:1989;68-91.
9. Harrington E.A., Bennett M.R., Fanidi A., Evan G.I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:1994;3286-3295.
10. Hernandez-Sanchez C., Werner H., Roberts C.T. Jr et al. Differential regulation of IGF-I receptor gene expression by IGF-I and basic fibroblast growth factor. J. Biol. Chem. 272:1997;4663-4670.
11. Karnieli E., Werner H., Rauscher III F.J. et al. The IGF-I receptor gene promoter is a molecular target for the Ewings' sarcoma-Wilms' tumor 1 fusion protein. J. Biol. Chem. 271:1996;19304-19309.
12. Kim S.O., Park J.G., Lee Y.I. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Cancer Res. 56:1996;3831-3836.
13. Kozma L.M., Weber M.J. Constitutive phosphorylation of the receptor for insulin-like growth factor I in cells transformed by the src oncogene. Mol. Cell Biol. 10:1990;3626-3634.
14. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Jr Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrinol. Rev. 16:1995;143-163.
15. Liu J.-P., Baker J., Perkins A.S., Robertson E.J., Estratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:1993;59-72.
16. O'Connor R., Kauffmann-Zeh A., Liu Y. et al. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol. 17:1997;427-435.
17. Ohlsson C., Kley N., Werner H., LeRoith D. p53 regulates IGF-I receptor expression and IGF-I induced tyrosine phosphorylation in an osteosarcoma cell line: Interaction between p53 and Sp1. Endocrinology. 139:1998;1101-1107.
18. Pietrzkowski Z., Lammers R., Carpenter G. et al. Constitutive expression of insulin-like growth factor I and insulin-like growth factor I receptor abrogates all requirements for exogenous growth factors. Cell Growth Diff. 3:1992;199-205.
19. Rauscher III F.J. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7:1993;896-903.
20. Reiss K., Ferber A., Travali S., Porcu P., Phillips P.D., Baserga R. The protooncogene c-myb increases the expression of insulin-like growth factor I and insulin-like growth factor I receptor messenger RNAs by a transcriptional mechanism. Cancer Res. 51:1991;5997-6000.
21. Resnicoff M., Abraham D., Yutanawiboonchai W. et al. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:1995;2463-2469.
22. Resnicoff M., Burgaud J.-L., Rotman H.L., Abraham D., Baserga R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res. 55:1995;3739-3741.
23. Rodriguez-Tarduchy G., Collins M.K.L., Garcia I., Lopez-Rivas A. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol. 149:1992;535-540.
24. Rubin R., Baserga R. Insulin-like growth factor-I receptor. Lab. Invest. 73:1995;311-331.
25. Rubini M., Werner H., Gandini E., Roberts C.T. Jr, LeRoith D., Baserga R. Platelet-derived growth factor increases the activity of the promoter of the IGF-I receptor gene. Exp. Cell Res. 211:1994;374-379.
26. Rubini M., Hongo A., D'Ambrosio C., Baserga R. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp. Cell Res. 230:1997;284-292.
27. Russell W.E., Van Wyk J.J., Pledger W.J. Inhibition of the mitogenic effect of plasma by a monoclonal antibody to somatomedin C. Proc. Natl. Acad. Sci. USA. 81:1984;2389-2393.
28. Saffer J.D., Jackson S.P., Annarella M.B. Developmental expression of Sp1 in the mouse. Mol. Cell Biol. 11:1991;2189-2199.
29. Sell C., Baserga R., Rubin R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55:1995;303-306.
30. Travali S., Reiss K., Ferber A. et al. Constitutively expressed c-myb abrogates the requirement for insulin-like growth factor I in 3T3 fibroblasts. Mol. Cell Biol. 11:1991;731-736.
31. Ullrich A., Gray A., Tam A.W. et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests determinants that define functional specificity. EMBO J. 5:1986;2503-2512.
32. Werner H., Woloschak M., Adamo M., Shen-Orr Z., Roberts C.T. Jr, LeRoith D. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA. 86:1989;7451-7455.
33. Werner H., Bach M.A., Stannard B., Roberts C.T. Jr, LeRoith D. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol. Endocrinol. 6:1992;1545-1558.
34. Werner H., Re G.G., Drummond I.A., Sukhatme V.P. et al. Increased expression of the insulin-like growth factor-I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms' tumor gene product. Proc. Natl. Acad. Sci. USA. 90:1993;5828-5832.
35. Werner H., Adamo M., Roberts C.T. Jr, LeRoith D. Molecular and cellular aspects of Insulin-like growth factor action. Litwack G. Vitamins and Hormones. 48:1994;1-58 Academic Press, San Diego.
36. Werner H., Rauscher III F.J., Sukhatme V.P., Drummond I.A., Roberts C.T. Jr, LeRoith D. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J. Biol. Chem. 269:1994;12577-12582.
37. Werner H., Shen-Orr Z., Rauscher III F.J. et al. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol. Cell Biol. 15:1995;3516-3522.
38. Werner H., Karnieli E., Rauscher III F.J., LeRoith D. Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA. 93:1996;8318-8323.